CClinicalTrials.gg
TerminatedNCT04168918Updated May 21, 2021

Effectiveness of a Group Psychological Intervention in Reducing Self-stigma Among Patients With Mental Disorders

An interventional study of Group psychological Intervention in Self-stigma, Self Efficacy and Quality of Life, sponsored by The University of The West Indies. Terminated at 1 site in Barbados. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-21.

Sponsored by The University of The West Indies · Not applicable, Interventional, and Supportive care

Why this study was terminated
Most participants did not complete the post-intervention questionnaire
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Non-randomized
Ages
18 Years to 69 Years
Sex
All
01

Study summary

At the Psychiatric Hospital, there are limited mental health professionals to offer the standard of care that is expected at a psychiatric institution. Psychotherapy is most affected. However, there are mental health professionals in training and long waiting times before clients are seen, which provides an opportunity for an intervention to be carried out. The purpose of the study therefore, is to determine whether a group psychological intervention can primarily reduce self-stigma among outpatients at the Psychiatric Hospital. The intervention's effects on self-efficacy and quality of life will also be assessed.

Read the detailed description

Study population: outpatients in the Outpatient Department at The Psychiatric Hospital

Target population: clients with two-weekly appointments

Procedures for recruitment and consent

Participants will be chosen using available lists of persons who come to clinic on a two-weekly basis on four(4) days of the week (every day except the day the Principal Investigator is responsible for conducting clinic), for two consecutive weeks. Twenty-six will be chosen each day (for eight (8) days) and randomized to intervention and treatment-as-usual (Thirteen (13) persons to each group). Participants will be selected based on the inclusion and exclusion criteria and consent will be obtained.

Randomization will be carried out by Stata 14

Sample size

Using the means and standard deviations for the Internalized Stigma of Mental Illness Inventory (ISMI) used in a randomized controlled trial and Stata 14 for sample size calculation, the sample size recommended is eighty-four (84) with forty-two (42) per group. This will give a power (for the study) of eighty per cent (80%).

However, the aim will be two-hundred and eight (208) clients based on the following:

  • Target population: two-hundred and fifty (250). Approximately twenty-five (25) patients come to clinic daily, most of whom come on a two-weekly basis. Therefore, this will allow eighty-three per cent (83%) of the population to be part of the study.
  • Maximum number of persons in a group- thirteen (13)
  • Maximum number of groups that can be held before clinic begins- one (1)
  • Time for thesis
  • Taking into account that persons may not be willing to participate and so aiming to include as many persons as possible

Method

There will be six (6) sessions covering six (6) topics. One topic will be covered at each session. Sessions will last sixty (60) to ninety (90) minutes.

Data collection

  • Administration of the ISMI, the General self-efficacy scale and World Health Organization (WHO)5 Well Being Index and a questionnaire to the intervention and control groups before the intervention and after the intervention. This will be done by a health professional not related to the study.

Permission was obtained from producer of ISMI. WHO5 Well-Being Index is free to use and General self-efficacy scale does not require permission, once referenced.

All three scales have been found to be valid and reliable.

  • A pilot study on 26 persons will be conducted to test the questionnaire and scales.
  • To ensure accurate completion of questionnaire and scales by each participant, each item will be read and explained before participants asked to select answer. Questions on clarification will be encouraged.Time will also be given after, for participants to read through answers if needed. Additionally, when collecting questionnaires and scales, the mental health professional will scan through to ensure all questions answered.

Questionnaires and scales will be identified using participants' record numbers to facilitate verification of information such as whether medications or health care provider changed during the course of the intervention.

Statistical analyses

  • Summary statistics
  • Regression analysis of endpoint score adjusting baseline score and looking at the difference between the intervention and treatment-as-usual groups.

Intention to treat analysis will be used.

  • Software to be used: Stata 14 Missing entries will be included in the analysis Data handling and record keeping

Questionnaires kept in secure room for at least five (5) years

02

Conditions studied

  • Self-stigma
  • Self Efficacy
  • Quality of Life
03

In context

Lead sponsor

The University of The West Indies is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Attend clinic every 2 weeks
  • Willingness to attend all sessions

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment that limits the participant from understanding material and answering questions
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Group Psychological Intervention

    One topic will be discussed at each of the six sessions using some principles from cognitive behavioral therapy and psychoeducation.

    Behavioral: Group psychological Intervention

  • No intervention
    Treatment-as-usual

    Participants will receive their usual care which involves being seen by a mental health professional (psychologist, psychiatrist/resident in psychiatry, or mental health nurse).

Interventions

  • BehavioralGroup psychological Intervention

    There will be 6 sessions covering 6 topics (Understanding mental disorders, Self-stigma, Social support, Substance use and mental illness, Self-help strategies, Available mental health services). Each session will begin with welcoming, reviewing what was done in the last session and home assignments (where applicable), question-guided discussion, lecture, group sharing and home assignment

06

What researchers measure

Primary outcomes

  1. Change in self-stigma

    Mean Change from Baseline in scores on the Internalized Stigma of Mental Illness Inventory (ISMI) after 6 sessions Each item is scored 1-4 (1=strongly disagree;4=strongly agree), yielding a total between 29 and 116. Higher scores indicate greater self-stigma.

    Time frame: From enrollment to the end of intervention at 12 weeks

Secondary outcomes

  1. Change in self-efficacy: General self-efficacy scale

    Mean Change from Baseline in scores on the General self-efficacy scale after 6 sessions Each item is scored 1-4 (1=not true at all; 4=exactly true) yielding a total between 10 and 40. Higher scores indicate more self-efficacy

    Time frame: From enrollment to the end of intervention at 12 weeks

  2. Change in quality of life: WHO5 Well Being Index

    Mean Change from Baseline in scores on the WHO5 Well Being Index after 6 sessions Each item is scored 0-5 (0=at no time; 5=all of the time) yielding between 0 and 25. Higher scores indicate better quality of life.

    Time frame: From enrollment to the end of intervention at 12 weeks

07

Study locations

1 site
  • The Psychiatric Hospital
    Bridgetown, Barbados
08

References and documents

Publications

  • Cuhadar D, Cam MO. Effectiveness of psychoeducation in reducing internalized stigmatization in patients with bipolar disorder. Arch Psychiatr Nurs. 2014 Feb;28(1):62-6. doi: 10.1016/j.apnu.2013.10.008. Epub 2013 Oct 28. PubMed 24506989 ↗
  • Schwarzer R, Jerusalem M. Generalized Self-Efficacy scale. In J. Weinman, S. Wright, & M. Johnston, Measures in health psychology: A user's portfolio. Causal and control beliefs (pp. 35-37). Windsor, UK: NFER-NELSON, 1995
  • Topp CW, Ostergaard SD, Sondergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-76. doi: 10.1159/000376585. Epub 2015 Mar 28. PubMed 25831962 ↗
  • Chang CC, Wu TH, Chen CY, Wang JD, Lin CY. Psychometric evaluation of the internalized stigma of mental illness scale for patients with mental illnesses: measurement invariance across time. PLoS One. 2014 Jun 2;9(6):e98767. doi: 10.1371/journal.pone.0098767. eCollection 2014. PubMed 24887440 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04168918
Lead sponsor
The University of The West Indies
Responsible party
Shani Venner (Postgraduate student, The University of The West Indies) — Principal investigator
First posted
Nov 19, 2019
Start date
Jan 7, 2020
Primary completion
Jan 24, 2020
Completion
Mar 6, 2020
Last update
May 21, 2021

Study contacts

Shani KM Venner, MBBS,MPH
principal investigator · University of the West Indies-Cave Hill Campus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion